<DOC>
	<DOC>NCT00557544</DOC>
	<brief_summary>This is a Randomized double blind trial with the aim to estimate the effectiveness of 3 therapeutic regimes per os on migraine pain: - metoclopramide 0,15 mg/kg + placebo - metoclopramide 0,15 mg/Kg + ketoprofen 1 mg/kg - ketoprofen 1 mg/Kg + placebo Intensity of pain will be measured with linear 1-10 scale or analogic McGrath type scale every 20 min. The main objective is the evaluation of healing times from pain in the 3 groups</brief_summary>
	<brief_title>Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Children 617 years old with migraine presenting in emergency room Informed consensus not obtained Occurring migraine still treated Hemiplegic migraine</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>migraine</keyword>
	<keyword>metoclopramide</keyword>
	<keyword>ketoprofen</keyword>
	<keyword>child</keyword>
</DOC>